[1] |
Tuberculosis Control Branch of Chinese Antituberculosis Association, The Youth Branch of Chinese Antituberculosis Association, Editorial Board of Chinese Journal of Antituberculosis.
Evidence-based guidelines for application of digital adherence technology in tuberculosis medication management in China
[J]. Chinese Journal of Antituberculosis, 2025, 47(4): 385-397.
|
[2] |
Yang Liangzi, Zhang Peize, Lu Shuihua.
Interpretation of World Health Organization’s Co-administration of Treatment for Drug-resistant Tuberculosis and Hepatitis C: 2024 Update
[J]. Chinese Journal of Antituberculosis, 2024, 46(8): 874-876.
|
[3] |
Chai Dongyu, Qin Shuyi, Zhang Ronghua, Zou Nannan, Wang Xin.
Analysis of risk factors for viral pneumonia combined with invasive pulmonary mycosis
[J]. Chinese Journal of Antituberculosis, 2024, 46(7): 750-755.
|
[4] |
Li Yao, Fang Zhe, Luo Danlin, Hu Yanmei, Tang Mi, Tang Zhigang, Wen Xinmin, Zhang Yong, Yao Bibo, Wang Qi, Yi Hengzhong.
Clinical characteristics and prognosis of patients with novel coronavirus infection complicated with pulmonary tuberculosis
[J]. Chinese Journal of Antituberculosis, 2024, 46(6): 687-698.
|
[5] |
Wang Senlu, Liu Nianqiang, Wang Xinqi, Cao Mingqin, Wang Le, Wang Xijiang.
Development and effectiveness of “Xinjiang Model” for tuberculosis prevention and control
[J]. Chinese Journal of Antituberculosis, 2024, 46(2): 141-144.
|
[6] |
Bao Liangliang, Wang Xinqi, Zhang Yan, Cao Mingqin.
Qualitative evaluation of the implementation status of tuberculosis prevention and control in Southern Xinjiang Uygur Autonomous Region: qualitative interviews based on grounded theories
[J]. Chinese Journal of Antituberculosis, 2024, 46(2): 151-157.
|
[7] |
Jia Fei, Cao Yanlin, Jiang Shiwen, Zhang Ke, Yi Min.
Comparison and enlightenment of international legislation experience on tuberculosis control
[J]. Chinese Journal of Antituberculosis, 2023, 45(3): 235-239.
|
[8] |
ZHANG Hui, ZHAO Yan-lin.
Strengthen multi-sectoral cooperation mechanism to further promote the tuberculosis prevention and control in China
[J]. Chinese Journal of Antituberculosis, 2022, 44(2): 115-119.
|
[9] |
Liu Eryong, Meng Qinglin, Wang Qian, Wang Jing, Zhou Lin.
Interpretation of WHO Guidelines on tuberculosis care and support
[J]. Chinese Journal of Antituberculosis, 2022, 44(12): 1249-1252.
|
[10] |
LI Ting, HE Jin-ge, XIA Lan, CHEN Chuang, XIAO Yue, LU Jia, WANG Dan-xia.
The impact of the COVID-19 epidemic on tuberculosis notification in Sichuan Province
[J]. Chinese Journal of Antituberculosis, 2021, 43(9): 929-938.
|
[11] |
CHEN Qiu-qi, DENG Guo-fang.
Discussion on the comorbidities and management of tuberculosis in China
[J]. Chinese Journal of Antituberculosis, 2021, 43(6): 546-549.
|
[12] |
National Clinical Research Center for Infectious Disease/, The Third People’s Hospital of Shenzhen, National Clinical Research Center for Metabolic Disease, The Second Xiangya Hospital of Central South University, Chinese Antituberculosis Association, Editorial Board of Chinese Journal of Antituberculosis.
Expert consensus on treatment and management of tuberculosis-diabetes mellitus
[J]. Chinese Journal of Antituberculosis, 2021, 43(1): 12-22.
|
[13] |
LI Tao, DU Xin, CHEN Wei, HUANG Fei, ZHAO Yan-lin, ZHANG Hui.
Review and prospect of tuberculosis management information surveillance and monitoring in China
[J]. Chinese Journal of Antituberculosis, 2020, 42(7): 657-661.
|
[14] |
LI Xiao-kun, YUAN Yan-li, YANG Guang-xu, WU Yuan-yuan.
Design and application of Tuberculosis Designated Hospital Information Management Platform in Changchun
[J]. Chinese Journal of Antituberculosis, 2020, 42(7): 671-675.
|
[15] |
LIU Guang-tian, LIU Tao, WANG Xiao-wei, LEI Juan, TIAN Xiao-mei, WANG Xiao-lin.
Application of “Internet+Medical Treatment” model in tuberculosis prevention and treatment in Ningxia
[J]. Chinese Journal of Antituberculosis, 2020, 42(7): 676-681.
|